Literature DB >> 16886610

Experimental model and immunohistochemical analyses of U87 human glioblastoma cell xenografts in immunosuppressed rat brains.

Tadej Strojnik1, Rajko Kavalar, Tamara T Lah.   

Abstract

BACKGROUND: To study the neuropathology and selected tumour markers of malignant gliomas, an animal glioma model was developed using the implantation of human glioblastoma clone U87 into rat brains.
MATERIALS AND METHODS: The U87 cell suspension, or precultured U87 tumour spheroids, were inoculated into the brain of 4-week-old cyclosporin A immunosuppressed Wistar rats. The resulting first generation tumours were then transferred, through serial transplantations to rats, to obtain second and third generation tumours. Brain tumour sections were examined for various known tumour markers by routine HE staining and immunohistochemical analyses.
RESULTS: The immunohistochemical analyses showed that p53, S100 protein, glial fibrillary acidic protein (GFAP) and synaptophysin expressions, initially present in the tissue culture, were gradually lost in later tumour generations, whereas nestin and musashi expressions increased, possibly indicating progressive tumour cell dedifferentation. Persistent kallikrein, CD68 and vimentin expressions in U87 cells, as well as in all the generations of tumours, may be related to the preservation of the mesenchymal cell phenotype in this tumorigenesis model. Decreased cathepsins expression indicated lower invasive potential, but increasing Ki-67 expression marked higher proliferation activity in the subsequent tumour generations. The strong immune reaction for FVIII in the second and third generation tumours correlated with the observed increase in vascular proliferation in these tumours.
CONCLUSION: A simple, and well-defined rat model of fast-growing glioma was established, providing a basis for further experimental studies of genetic and protein expression fingerprints during human glioma tumorigenesis.

Entities:  

Mesh:

Year:  2006        PMID: 16886610

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  12 in total

1.  Immunohistochemical localization of caspase-3, caspase-9 and Bax in U87 glioblastoma xenografts.

Authors:  Otilia Zarnescu; Felix Mircea Brehar; Mihaela Chivu; Alexandru Vladimir Ciurea
Journal:  J Mol Histol       Date:  2008-09-24       Impact factor: 2.611

2.  Xenograft transplantation of human malignant astrocytoma cells into immunodeficient rats: an experimental model of glioblastoma.

Authors:  Flávio Key Miura; Maria Jose Ferreira Alves; Mussya Cisotto Rocha; Roseli da Silva; Sueli Mieko Oba-Shinjo; Suely Kazue Nagahashi Marie
Journal:  Clinics (Sao Paulo)       Date:  2010-03       Impact factor: 2.365

3.  The RNA-Binding Protein Musashi1: A Major Player in Intestinal Epithelium Renewal and Colon Cancer Development.

Authors:  Michelina Plateroti; Patricia Rosa de Araujo; Acarizia Eduardo da Silva; Luiz O F Penalva
Journal:  Curr Colorectal Cancer Rep       Date:  2012

4.  Tumor-specific activity of cellular regulatory elements is down-regulated upon insertion into the herpes simplex virus genome.

Authors:  Mandy Glass; Ariane Söling; Martin Messerle
Journal:  J Neurovirol       Date:  2008-11       Impact factor: 2.643

Review 5.  Hypothesis: are neoplastic macrophages/microglia present in glioblastoma multiforme?

Authors:  Leanne C Huysentruyt; Zeynep Akgoc; Thomas N Seyfried
Journal:  ASN Neuro       Date:  2011-09-22       Impact factor: 4.146

6.  Small-molecule agonists of mammalian Diaphanous-related (mDia) formins reveal an effective glioblastoma anti-invasion strategy.

Authors:  Jessica D Arden; Kari I Lavik; Kaitlin A Rubinic; Nicolas Chiaia; Sadik A Khuder; Marthe J Howard; Andrea L Nestor-Kalinoski; Arthur S Alberts; Kathryn M Eisenmann
Journal:  Mol Biol Cell       Date:  2015-09-09       Impact factor: 4.138

7.  Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model.

Authors:  Laura Mercurio; Maria Antonietta Ajmone-Cat; Serena Cecchetti; Alessandro Ricci; Giuseppina Bozzuto; Agnese Molinari; Isabella Manni; Bianca Pollo; Stefania Scala; Giulia Carpinelli; Luisa Minghetti
Journal:  J Exp Clin Cancer Res       Date:  2016-03-25

8.  Antiangiogenic therapy for glioma.

Authors:  Valentina Cea; Carlo Sala; Chiara Verpelli
Journal:  J Signal Transduct       Date:  2012-07-08

9.  Inhibition of U-87 MG glioblastoma by AN-152 (AEZS-108), a targeted cytotoxic analog of luteinizing hormone-releasing hormone.

Authors:  Miklos Jaszberenyi; Andrew V Schally; Norman L Block; Mehrdad Nadji; Irving Vidaurre; Luca Szalontay; Ferenc G Rick
Journal:  Oncotarget       Date:  2013-03

Review 10.  A systematic review and meta-analysis of gene therapy in animal models of cerebral glioma: why did promise not translate to human therapy?

Authors:  T C Hirst; H M Vesterinen; S Conlin; K J Egan; A Antonic; A Lawson McLean; M R Macleod; R Grant; P M Brennan; E S Sena; I R Whittle
Journal:  Evid Based Preclin Med       Date:  2015-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.